Literature DB >> 29551484

Trend of seizure remission in patients with tuberous sclerosis complex: A retrospective medical review.

Chang-Ching Wei1, Ji-Nan Sheu2, Jung-Tung Liu3, Sheng-Hui Yang4, I-Ching Chou5, Jeng-Dau Tsai6.   

Abstract

BACKGROUND: Seizures in tuberous sclerosis complex (TSC) tend to be intractable over time and become a subsequent psychological burden for the patients. The purpose of the current study was to describe the onset, phenotype, and factors associated with seizure remission in patients with TSC.
METHODS: Patients diagnosed with TSC between 2009 and 2015 completed a questionnaire interview and underwent a systematic evaluation, including a medical review of their epilepsy history and neurobehavioral disorder assessment.
RESULTS: Of the 61 patients, 50 patients (82.0%) had a positive seizure history. The active (n = 34) and seizure remission (n = 16) groups showed significant differences in age, neurobehavioral disorder, history of refractory epilepsy, and onset age (p < 0.001, p < 0.05, p < 0.05, and p < 0.05, respectively). The remission rates were 33.3% and 38.5% for those aged 6-18 years and over 18 years, respectively (p for trend = 0.01).
CONCLUSION: Seizure remission can occur in adulthood. It shows a high correlation with patient age, minor refractory epilepsy, and neurobehavioral disorders.
Copyright © 2018. Published by Elsevier Taiwan LLC.

Entities:  

Keywords:  Refractory epilepsy; Seizure remission; Tuberous sclerosis complex

Mesh:

Year:  2018        PMID: 29551484     DOI: 10.1016/j.jcma.2018.02.001

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  4 in total

1.  Epilepsy in adult patients with tuberous sclerosis complex.

Authors:  Aglaia Vignoli; Francesca La Briola; Katherine Turner; Angela Peron; Chiara Vannicola; Valentina Chiesa; Elena Zambrelli; Fabio Bruschi; Ilaria Viganò; Maria Paola Canevini
Journal:  Acta Neurol Scand       Date:  2021-03-22       Impact factor: 3.209

2.  Malignant perivascular epithelioid cell tumor in the female genital tract: Preferred reporting items for systematic reviews and meta-analyses.

Authors:  Chia-Hao Liu; Wei-Ting Chao; Shih-Chieh Lin; Hei-Yu Lau; Hua-Hsi Wu; Peng-Hui Wang
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

Review 3.  Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy.

Authors:  Jean Christopher Chamcheu; Tithi Roy; Mohammad Burhan Uddin; Sergette Banang-Mbeumi; Roxane-Cherille N Chamcheu; Anthony L Walker; Yong-Yu Liu; Shile Huang
Journal:  Cells       Date:  2019-07-31       Impact factor: 6.600

4.  Natural history of a fibrous cephalic plaque and sustained eight decade follow-up in an 80 year old with tuberous sclerosis complex type 2.

Authors:  Claire W Kirk; Deirdre E Donnelly; Rachel Hardy; Charles W Shepherd; Patrick J Morrison
Journal:  Ulster Med J       Date:  2020-02-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.